ibritumomab tiuxetan (i-bri-too-mo-mab tye-uks-i-tan)
Pharmacologic: monoclonal antibodies, radioisotopes
Relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma (including rituximab-resistant).
Ibritumomab tiuxetan is a monoclonal antibody linked to a radioisotope that targets white blood cells, including malignant ones. Used in combination with rituximab as part of a two-step process using indium-111 (step 1) and yttrium-90 (step 2) ibritumomab tiuxetan. Therapeutic Effects: Decreased spread of lymphoma.
Adverse Reactions/Side Effects
CNS: anxiety, dizziness. EENT: rhinitis. Resp: dyspnea, increased cough, bronchospasm. GI: abdominal pain, anorexia, diarrhea, nausea, vomiting. Derm: ecchymoses, pruritus. Hemat: LEUKOPENIA, THROMBOCYTOPENIA, anemia. MS: arthralgia. Misc: INFECTIONS, INFUSION REACTIONS, ALLERGIC REACTIONS, INCLUDING ANAPHYLAXIS, secondary malignancies.
PHYSICAL THERAPY IMPLICATIONS
Examination and Evaluation
Be alert for signs of allergic reactions and anaphylaxis. Reactions include pulmonary symptoms (tightness in the throat and chest, wheezing, cough, dyspnea) and skin reactions (rash, pruritus, urticaria, burning skin, swelling in the face). Be especially alert for these signs after drug infusion (infusion reactions). Notify physician or nursing staff immediately if these reactions occur.
Monitor signs of bone marrow suppression, including leukopenia (fever, sore throat, signs of infection), thrombocytopenia (bruising, nose bleeds, bleeding gums), or unusual weakness and fatigue that might be due to anemia. Notify physician of these signs immediately.
Be alert for signs of infection, including fever, sore throat, chills, nausea, vomiting, diarrhea, and localized inflammation. Notify physician or nursing staff of these signs immediately.
Monitor signs of secondary malignancy, including a change in bowel or bladder habits, nonhealing sores, unusual bleeding or discharge, a lump in the breast or other parts of the body, chronic indigestion or difficulty in swallowing, obvious changes in a wart or mole, and persistent coughing or hoarseness. Report these signs to the physician immediately.
Assess symptoms of bronchospasm (wheezing, coughing, tightness in chest) or other prolonged or severe respiratory problems (difficult or labored breathing). Perform pulmonary function tests to quantify suspected changes in ventilation and respiration (See Appendices I, J, K).
Assess dizziness that might affect gait, balance, and other functional activities (See Appendix C). Report balance problems and functional limitations to the physician and nursing staff, and caution the patient and family/caregivers to guard against falls and trauma.
Assess any increased joint pain to rule out musculoskeletal pathology; that is, try to determine if pain is drug induced rather than caused by anatomic or biomechanical problems.
Log In to View More
If your institution is currently a subscriber
of the F.A. Davis PT Collection please sign in below.
If your institution is not a subscriber
please click here
to learn more.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.